Wednesday, April 22, 2026
33.4 C
Bengaluru

Medicinman App

[wpfilebase tag=file id=73 tpl=download-button /]

Inside this Issue

1. FFE 2016 Takeaway: Sales Coaching is Critical to Frontline Success by K. Hariram

Frontline managers need to be taught how to coach Reps for sales success.

2. Do You have the Doctor’s Ear? by Suman Deb

Insights into how Doctors schedule appointments with Medical Reps and how to take advantage.

3. BOOK REVIEW: “Total Communication” by Vivek Hattangadi reviewed by K. Hariram

A complete guide to verbal and non-verbal communication for the pharma professional.

4. Standard Operating Procedures: Good or Evil? by Pankaj Mehrotra

Standard Operating Procedures (“SOPs”) can either boost or burden a company’s operations – the onus is on the frontline manager.

5. Up-Skilling for Growth by P. S. Parameswaran

As the fastest growing major economy, India offers tremendous opportunity for growth. Up-skilling the field force is crucial to successfully harness this opportunity.

Hot this week

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune

In the pharmaceutical world, we often focus on the...

Topics

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img